Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
09 10월 2024 - 5:29AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
(AMENDMENT NO. 2)
ABEONA THERAPEUTICS INC. |
(Name of Issuer) |
COMMON STOCK, PAR VALUE $0.01 PER SHARE |
(Title of Class of Securities) |
SEPTEMBER 30, 2024 |
(Date of event which requires filing of this statement) |
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
o Rule 13d-1(b)
þ Rule 13d-1(c)
o Rule 13d-1(d)
The remainder of this cover page shall be filled
out for a reporting persons initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this
cover page shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the notes).
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
2 |
|
of |
|
11 |
|
|
1 |
NAMES OF REPORTING PERSONS
Integrated Core Strategies (US) LLC |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware |
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
-0- |
6 |
SHARED VOTING POWER
2,267,875 |
7 |
SOLE DISPOSITIVE POWER
-0- |
8 |
SHARED DISPOSITIVE
POWER
2,267,875 |
|
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,267,875 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
o
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9)
5.2% |
12 |
TYPE OF REPORTING PERSON
OO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
3 |
|
of |
|
11 |
|
|
1 |
NAMES OF REPORTING PERSONS
Millennium Management LLC |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware |
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
-0- |
6 |
SHARED VOTING POWER
2,301,628 |
7 |
SOLE DISPOSITIVE POWER
-0- |
8 |
SHARED DISPOSITIVE POWER
2,301,628 |
|
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,301,628 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
o
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9)
5.3% |
12 |
TYPE OF REPORTING PERSON
OO |
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
4 |
|
of |
|
11 |
|
|
1 |
NAMES OF REPORTING PERSONS
Millennium Group Management LLC |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware |
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
-0- |
6 |
SHARED VOTING POWER
2,301,628 |
7 |
SOLE DISPOSITIVE POWER
-0- |
8 |
SHARED DISPOSITIVE POWER
2,301,628 |
|
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,301,628 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
o
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9)
5.3% |
12 |
TYPE OF REPORTING PERSON
OO |
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
5 |
|
of |
|
11 |
|
|
1 |
NAMES OF REPORTING PERSONS
Israel A. Englander |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United
States |
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
-0- |
6 |
SHARED VOTING POWER
2,301,628 |
7 |
SOLE DISPOSITIVE POWER
-0- |
8 |
SHARED DISPOSITIVE POWER
2,301,628 |
|
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,301,628 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
o
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9)
5.3% |
12 |
TYPE OF REPORTING
PERSON
IN |
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
6 |
|
of |
|
11 |
|
|
Item 1. |
|
|
|
(a) |
Name of
Issuer: |
|
|
|
|
|
Abeona Therapeutics Inc.
|
|
|
|
|
(b) |
Address of Issuers Principal
Executive Offices: |
|
|
|
|
|
6555 Carnegie Avenue, 4th Floor Cleveland, Ohio 44103
|
|
|
|
Item 2. |
(a) |
Name of Person
Filing: |
|
(b) |
Address of Principal Business
Office: |
|
(c) |
Citizenship: |
|
|
|
|
|
Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York
10022 Citizenship: Delaware |
|
|
|
|
|
Millennium Management LLC 399 Park Avenue New York, New York
10022 Citizenship: Delaware |
|
|
|
|
|
Millennium Group Management LLC
399 Park Avenue New York, New York 10022 Citizenship:
Delaware |
|
|
|
|
|
Israel A. Englander c/o
Millennium Management LLC 399 Park Avenue New York, New York
10022 Citizenship: United States |
|
|
|
|
(d) |
Title of Class of
Securities: |
|
|
|
|
|
common stock, par value $0.01 per share ("Common Stock") |
|
|
|
|
(e) |
CUSIP Number: |
|
|
|
|
|
00289Y206 |
|
|
|
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is
a:
|
|
|
|
(a) |
|
o |
|
Broker or dealer
registered under section 15 of the Act (15 U.S.C. 78o); |
|
|
|
|
|
|
|
|
|
(b) |
|
o |
|
Bank as defined in
section 3(a)(6) of the Act (15 U.S.C. 78c); |
|
|
|
|
|
|
|
|
|
(c) |
|
o |
|
Insurance company as
defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
|
|
|
|
|
|
|
|
|
(d) |
|
o |
|
Investment company
registered under section 8 of the Investment Company Act of 1940 (15
U.S.C. 80a-8); |
|
|
|
|
|
|
|
|
|
(e) |
|
o |
|
An investment adviser
in accordance with
§240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
|
|
|
|
|
|
(f) |
|
o |
|
An employee benefit
plan or endowment fund in accordance with
§240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
7 |
|
of |
|
11 |
|
|
|
|
|
|
|
|
|
|
|
(g) |
|
o |
|
A parent holding
company or control person in accordance with
§240.13d-1(b)(1)(ii)(G); |
|
|
|
|
|
|
|
|
|
|
|
(h) |
|
o |
|
A savings association
as defined in Section 3(b) of the Federal Deposit Insurance Act (12
U.S.C. 1813); |
|
|
|
|
|
|
|
|
|
(i) |
|
o |
|
A church plan that is
excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.
80a-3); |
|
|
|
|
|
|
|
|
|
(j) |
|
o |
|
Group, in accordance
with §240.13d-1(b)(1)(ii)(J). |
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount Beneficially Owned:
See response to Item 9 on each cover page.
(b) Percent of Class:
See response to Item 11 on each cover page.
(c) Number of shares as to which such person
has:
(i) Sole power to vote or to direct the vote
See response to Item 5 on each cover page.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
8 |
|
of |
|
11 |
(ii) Shared power to vote or to direct the vote
See response to Item 6 on each cover page.
(iii) Sole power to dispose or to direct the disposition of
See response to Item 7 on each cover page.
(iv) Shared power to dispose or to direct the disposition of
See response to Item 8 on each cover page.
The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group
See Exhibit I.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
9 |
|
of |
|
11 |
Exhibits:
Exhibit I: Joint Filing Agreement, dated as of October 7, 2024, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP
No. |
|
00289Y206 |
SCHEDULE 13G |
Page |
|
10 |
|
of |
|
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SIGNATURE |
|
|
|
|
|
|
|
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
Dated: October 7, 2024
|
|
INTEGRATED CORE STRATEGIES (US) LLC
By: Integrated Holding Group LP, its Managing Member
By: Millennium Management LLC, its General Partner
|
|
By: /s/Gil Raviv |
Name: Gil Raviv
Title: Global General Counsel
|
MILLENNIUM MANAGEMENT
LLC |
By: /s/Gil Raviv |
Name: Gil Raviv
Title: Global General Counsel
|
MILLENNIUM GROUP MANAGEMENT
LLC |
By: /s/Gil Raviv |
Name: Gil Raviv
Title: Global General Counsel
|
|
/s/ Israel A.
Englander
|
Israel
A. Englander
|
Abeona Therapeutics (NASDAQ:ABEO)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Abeona Therapeutics (NASDAQ:ABEO)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] 0년 15월 11일, 2024 (1 주 전) • Edgar (US Regulatory) |
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] 0년 14월 11일, 2024 (1 주 전) • Edgar (US Regulatory) |
Form 10-Q - Quarterly report [Sections 13 or 15(d)] 0년 14월 11일, 2024 (1 주 전) • Edgar (US Regulatory) |
Form 8-K - Current report 0년 14월 11일, 2024 (1 주 전) • Edgar (US Regulatory) |
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates 0년 14월 11일, 2024 (1 주 전) • GlobeNewswire Inc. |
Form DEF 14A - Other definitive proxy statements 0년 13월 11일, 2024 (2 주 전) • Edgar (US Regulatory) |
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa 0년 12월 11일, 2024 (2 주 전) • GlobeNewswire Inc. |
Abeona Therapeutics® Announces Participation in November Investor Conferences 0년 4월 11일, 2024 (3 주 전) • GlobeNewswire Inc. |
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 0년 1월 11일, 2024 (3 주 전) • GlobeNewswire Inc. |
Form 8-K - Current report 0년 29월 10일, 2024 (4 주 전) • Edgar (US Regulatory) |
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration 0년 29월 10일, 2024 (4 주 전) • GlobeNewswire Inc. |
Form 4 - Statement of changes in beneficial ownership of securities 0년 18월 10일, 2024 (1 월 전) • Edgar (US Regulatory) |
More Abeona Therapeutics Inc News Articles
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.